Genetic and Inflammatory Biomarkers Classify Small Intestine Inflammation in Asymptomatic First-degree Relatives of Patients With Crohn's Disease

Inflammatory Bowel Disease

Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease

Inflamm Bowel Dis.

Turpin W, Espin-Garcia O, Bedrani L, Madsen K, Meddings JB, Raygoza Garay JA, Silverberg MS, Smith MI, Griffiths AM, Moayyedi P, Marshall JK, Mack D, Seidman EG, Ropeleski M, Feagan BG, Jacobson K, Turner D, Walters T, Paterson AD, CCC GEM Project Research Consortium ., Xu W, Croitoru K

doi: 10.1093/ibd/izz116.

Inflammatory Bowel Disease

Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease

Inflamm Bowel Dis.

Ferrer-Picón E, Dotti I, Corraliza AM, Mayorgas A, Esteller M, Perales JC, Ricart E, Masamunt MC, Carrasco A, Tristán E, Esteve M, Salas A

doi: 10.1093/ibd/izz119.

Inflammatory Bowel Disease

Systemic molecular mediators of inflammation differentiate between Crohn's disease and ulcerative colitis, implicating threshold levels of IL-10 and relative ratios of pro-inflammatory cytokines in therapy

J Crohns Colitis.

Kiernan MG, Coffey JC, Sahebally SM, Tibbitts P, Lyons EM, O'Leary E, Olowabi F, Dunne CP

doi: 10.1093/ecco-jcc/jjz117.

Inflammatory Bowel Disease

Development and validation of a patient-reported score to screen for mucosal inflammation in inflammatory bowel disease

J Crohns Colitis.

de Jong MJ, Roosen D, Degens JHRJ, van den Heuvel TRA, Romberg M, Hameeteman W, Bodelier AGL, Romanko I, Lukas M5, Winkens B, Markus T, Masclee AAM, van Tubergen A, Jonkers DMAE, Pierik MJ

doi: 10.1093/ecco-jcc/jjy196.

Inflammatory Bowel Disease

Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease

Dig Dis Sci.

Cohen-Mekelburg S, Tafesh Z, Coburn E, Weg R, Malik N, Webb C, Hammad H, Scherl E, Bosworth BP

doi: 10.1007/

Inflammatory Bowel Disease

Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative Colitis

Z Gastroenterol.

Hüppe A, Langbrandtner J, Häuser W, Raspe H, Bokemeyer B

doi: 10.1055/a-0605-4080.

Inflammatory Bowel Disease

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease

BMC Gastroenterol.

E Penna FGC, Rosa RM, da Cunha PFS, de Souza SCS, de Abreu Ferrari ML

doi: 10.1186/s12876-020-1183-x.

Inflammatory Bowel Disease

The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort

Inflamm Bowel Dis.

Madanchi M, Fagagnini S, Fournier N, Biedermann L, Zeitz J, Battegay E, Zimmerli L, Vavricka SR, Rogler G, Scharl M; Swiss IBD Cohort Study Group.

doi: 10.1093/ibd/izy054.

Inflammatory Bowel Disease

Colonoids From Patients With Pediatric Inflammatory Bowel Disease Exhibit Decreased Growth Associated With Inflammation Severity and Durable Upregulation of Antigen Presentation Genes

Inflamm Bowel Dis.

Kelsen JR, Dawany N, Conrad MA, Karakasheva TA, Maurer K, Wei JM, Uman S, Dent MH, Behera R, Bryant LM, Ma X, Moreira L, Chatterji P, Shraim R, Merz A, Mizuno R, Simon LA, Muir AB, Giraudo C, Behrens EM, Whelan KA, Devoto M, Russo PA, Andres SF, Sullivan KE, Hamilton KE

doi: 10.1093/ibd/izaa145.

Related content

Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease

Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease

Systemic molecular mediators of inflammation differentiate between Crohn's disease and ulcerative colitis, implicating threshold levels of IL-10 and relative ratios of pro-inflammatory cytokines in therapy

Development and validation of a patient-reported score to screen for mucosal inflammation in inflammatory bowel disease

Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease

Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative Colitis

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease

The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort

Colonoids From Patients With Pediatric Inflammatory Bowel Disease Exhibit Decreased Growth Associated With Inflammation Severity and Durable Upregulation of Antigen Presentation Genes